Abstract
Cerebral toxoplasmosis is an opportunistic infection, occurring mostly in immunosuppressed patients due to the reactivation of latent Toxoplasma cysts. The cerebral comorbidity in diabetic patients tends to intensify the burden of pathogenic infection within the brain. The aim of this work was to study the effect of cerebral toxoplasmosis in experimentally infected hyperglycemic mice, on histopathology and glial fibrillary acidic protein (GFAP) expression, compared to normoglycemic mice at different time intervals. Vasculopathy was exclusively observed in diabetic groups, with features of increased severity during Toxoplasma infection. Gliosis was observed in diabetic groups, while hyperactive astroglial activity was detected in normoglycemic groups, especially at 6 weeks of infection. GFAP expression showed significant up-regulation in normoglycemic mice at 6 weeks of infection (40.03 ± 1.41) afterwards, it decreased to 22.22 ± 3.14 at 12 weeks which was statistically insignificant to the normal level, possibly indicating the successful Toxoplasma stage transformation (to bradyzoite), thereby limiting the infection within the brain. In hyperglycemic infected groups, GFAP was significantly down-regulated, in both acute and chronic phases of infection, most likely indicating failure of stage transformation and infection limitation. This may expose those vulnerable groups to the risk of dissemination, resulting in life-threatening diffuse encephalitis. The current study emphasized the importance of rapid diagnosis of Toxoplasma infection in diabetic subjects, and highlighted the value of using GFAP as a neurological indicator of disease progression in those comorbid cases.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author (Hanaa Omar Fadl), upon reasonable request.
References
Al-Isa AN, Thalib L, Akanji AO (2010) Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 208(2):543–549
Bandeira SDM, Da Fonseca LJS, Guedes GDS, Rabelo LA, Goulart MO, Vasconcelos SML (2013) Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci 14(2):3265–3284
Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462(1–3):67–71
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R (2020) Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 16(5):442–449
Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27(1):117–120
Cabral GR, Wang ZT, Sibley LD, DaMatta RA (2018) Inhibition of nitric oxide production in activated macrophages caused by Toxoplasma gondii infection occurs by distinct mechanisms in different mouse macrophage cell lines. Front Microbiol 9:1936
Casqueiro J, Casqueiro J, Alves C (2012) Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab 16(Suppl. 1):27. https://doi.org/10.4103/2230-8210.94253
Chang J, Yan J, Li X, Liu N, Zheng R, Zhong Y (2021) Update on the mechanisms of tubular cell injury in diabetic kidney disease. Front Med 8:661076. https://doi.org/10.3389/fmed.2021.661076
Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW et al (2018) IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281
Crotti A, Ransohoff RM (2016) Microglial physiology and pathophysiology: insights from genome-wide transcriptional profiling. Immunity 44(3):505–515
Cullen DK, Simon CM, LaPlaca MC (2007) Strain ratedependent induction of reactive astrogliosis and cell death in threedimensional neuronal–astrocytic co-cultures. Brain Res 1158:103–115
Dalimi A, Abdoli A (2012) Latent toxoplasmosis and human. Iran J Parasitol 7(1):1
Dellacasa-Lindberg I, Fuks JM, Arrighi RB, Lambert H, Wallin RP, Chambers BJ, Barragan A (2011) Migratory activation of primary cortical microglia upon infection with Toxoplasma gondii. Infect Immun 79(8):3046–3052
Dincel GC, Atmaca HT (2015) Nitric oxide production increases during Toxoplasma gondii encephalitis in mice. Exp Parasitol 156:104–112
Dubey JP (2016) Toxoplasmosis of animals and humans. CRC Press, Boca Raton
Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W (2000) Increased cerebral glucose utilization and decreased glucose transporter GLUT1 during chronic hyperglycemia in rat brain. Brain Res 858(2):338–347
Elfadaly HA, Hassanain MA, Shaapan RM, Hassanain NA, Barakat AM (2015) Corticosteroids opportunist higher Toxoplasma gondii brain cysts in latent infected mice. Int J Zool Res 11(4):169–176
Elsheikha HM, Marra CM, Zhu X-Q (2021) Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev 34(1):e00115-e119. https://doi.org/10.1128/CMR.00115-19
Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAPthirty-one years (1969–2000). Neurochem Res 25(9–10):1439–1451
Firouzeh N, Ziaali N, Sheibani V, Doustimotlagh AH, Afgar A, Zamanpour M, Keshavarz H, Shojaee S, Shafiei R, Esmaeilpour K, Babaei Z (2021) Chronic Toxoplasma gondii infection potentiates parkinson’s disease course in mice model. Iran J Parasitol 16(4):527–537. https://doi.org/10.18502/ijpa.v16i4.7863
Fernández-Calle R, Vicente-Rodríguez M, Gramage E et al (2017) Pleiotrophin regulates microglia-mediated neuroinflammation. J Neuroinflammation 14(1):46
Gillies MC, Su T, Stayt J, Simpson JM, Naidoo D, Salonikas C (1997) Effect of high glucose on permeability of retinal capillary endothelium in vitro. Invest Ophthalmol vis Sci 38(3):635–642
Goligorsky MS (2005) Endothelial cell dysfunction: can’t live with it, how to live without it. Am J Physiol-Renal Physiol 288(5):F871–F880
Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O (2015) Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Glob Health 81(6):814–820
Hol EM, Pekny M (2015) Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervoussystem. Curr Opin Cell Biol 32:121–130
Hosseini SA, Amouei A, Sharif M, Sarvi S, Galal L, Javidnia J et al (2019) Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples Epidemiology & Infection: 147
Isaacs A, Baker M, Wavrant-De Vrièze F, Hutton M (1998) Determination of the gene structure of human GFAP and absence of coding region mutations associated with frontotemporal dementia with parkinsonism linked to chromosome 17. Genomics 51(1):152–154
Khattab HM, El Bassiouni SO, Abuelela MH, Abd Elsalam DO (2019) Seroprevalence of Toxoplasma gondii among a group of Egyptian patients with type I diabetes mellitus. Bull Natl Res Centre 43(1):1–7
Knapp S (2013) Diabetes and infection: is there a link?-A minireview. Gerontology 59(2):99–104
Kolluru GK, Bir SC, Kevil CG (2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012
Kumar S, Zhuo L (2010) Longitudinal in vivo imaging of retinal gliosis in a diabetic mouse model. Exp Eye Res 91(4):530–536
Li Q, Barres BA (2018) Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol 18(4):225–324
Li YX, Xin H, Zhang XY, Wei CY, Duan YH, Wang HF, Niu HT (2018) Toxoplasma gondii infection in diabetes mellitus patients in China: seroprevalence, risk factors, and case-control studies. BioMed Res Int 2018
Liang YS, Bruce JI, Botd DA (1987) Proceeding of the First Sino-American symposium 1: 34–48
Malone JI (2016) Diabetic central neuropathy: CNS damage related to hyperglycemia. Diabetes 65(2):355–357
Mayoral J, Cristina MD, Carruthers VB, Weiss LM (2020) Toxoplasma gondii: bradyzoite differentiation in vitro and in vivo. Toxoplasma gondii. Humana, New York, NY, pp 269–282
Molan AL, Ismail MH (2017) Study the possible association between toxoplasmosis and diabetes mellitus in IRAQ. World J Pharm Pharm Sci 6(3):85–96
Montoya JG, Remington JS (2000) Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, (eds) Principles and practice of infectious diseases 5th edn. New York, NY, Churchill Livingstone, pp 2858–2888
Nagayach A, Patro N, Patro I (2014) Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis 29(3):747–761
Nasuhidehnavi A, Yap GS (2021) Microglia and astrocyte responses to neuropathogenic protozoan parasites. Faculty Reviews 10
Ottlecz A, Bensaoula T (1996) Captopril ameliorates the decreased Na+, K (+)-ATPase activity in the retina of streptozotocininduced diabetic rats. Invest Ophthalmol vis Sci 37(8):1633–1641
Quesenberry K, Carpenter JW (2011) Ferrets, Rabbits and Rodents-E-Book. In: Clinical Medicine and Surgery. Elsevier Health Sciences
Ramos-Vara JA, Miller MA (2014) When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry—the red, brown, and blue technique. Vet Pathol 51(1):42–87
Ridet JL, Privat A, Malhotra SK, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20(12):570–577
Rungger-Brandle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol vis Sci 41(7):1971–1980
Saad AE, Ashour DS, Dawood LM, El-Shorbagy SH (2020) Age-related changes in cerebral congenital toxoplasmosis: histopathological and immunohistochemical evaluation. J Neuroimmunol 348:577384
Saravia FE, Revsin Y, Deniselle MCG, Gonzalez SL, Roig P, Lima A et al (2002) Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 957(2):345–353
Schlüter D, Barragan A (2019) Advances and challenges in understanding cerebral toxoplasmosis. Front Immunol 10:242
Seabra SH, de Souza W, DaMatta RA (2002) Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Exp Parasitol 100(1):62–70
Selseleh M, Modarressi MH, Shojaee S, Mohebali M, Eshraghian MR, Selseleh M, Keshavarz H (2013) Brain tissue cysts in infected mice with RH-strain of Toxoplasma gondii and evaluation of BAG1 and SAG1 genes expression. Iran J Parasitol 8(1):40
Shirbazou S, Delpisheh A, Mokhetari R, Tavakoli G (2013) Serologic detection of anti Toxoplasma gondii infection in diabetic patients. Iran Red Crescent Med J 15(8):701
Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32(12):638–647
Stenzel W, Soltek S, Schlüter D, Deckert M (2004) The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J Neuropathol Exp Neurol 63(6):631–640
Tanaka Y (2008) Immunosuppressive mechanisms in diabetes mellitus. Nihon Rinsho 66(12): 2233–2237. PMid: 19069085
Tedford E, McConkey G (2017) Neurophysiological changes induced by chronic Toxoplasma gondii infection. Pathogens 6(2):19
Tenter AM, Heckeroth AR, Weiss LM (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30(12–13):1217–1258
Venkatesh K, Srikanth L, Vengamma B, Chandrasekhar C, Sanjeevkumar A, Prasad BCM, Sarma PVGK (2013) In vitro differentiation of cultured human CD34+ cells into astrocytes. Neurol India 61(4):383
Wu KK, Huan Y (2008) Streptozotocin-induced diabetic models in mice and rats. Curr Protocols Pharmacol 70(1):5–47
Acknowledgements
We would like to express our gratitude to all the members that collaborated in this study.
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
AAA and MAS; Methodology: GAA, M-EAF and MAB; Data collection and analysis: AAA, MAS, MAB and GAA; Writing the paper: HOF, AAA and M-EAF; Reviewing and editing: HOF, AAA, AAA and M-EAF. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study protocol was approved by the ethical committee of Kasr-Alainy School of Medicine, Theodor Bilharz Research Institute (TBRI), and The Institutional Animal Care & Use Committee (IACUC) of Cairo University (research number: CU-IACUC, III-38-21).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abdelhamid, G.A., Abdelaal, A.A., Shalaby, M.A. et al. Type-1 diabetes mellitus down-regulated local cerebral glial fibrillary acidic protein expression in experimental toxoplasmosis. J Parasit Dis 47, 319–328 (2023). https://doi.org/10.1007/s12639-023-01573-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-023-01573-y